Friday, November 21, 2008 - 7:20PM EST

Clinical Trials

1. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.

Author
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A;
Institution
Pyrah Department of Urology, St. James University Hospital, Becket Street, Leeds, UK. ian.eardley@leedsth.nhs.uk
Journal
BJU Int. 2007 Jul;100(1):122-9.
Abstract URL
Click here to view abstract

2. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).

Author
Bohm M; Baumhakel M; Probstfield JL; Schmieder R; Yusuf S; Zhao F; Koon T;
Institution
Klinik fur Innere Medizin III des Universitatsklinikum des Saarlandes, Saarland, Homburg, Germany. boehm@med-in.uni-saarland.de
Journal
Am Heart J. 2007 Jul;154(1):94-101.
Abstract URL
Click here to view abstract

3. The multinational Men's Attitudes to Life Events and Sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment-seeking patterns in men with erectile dysfunction.

Author
Eardley I; Fisher W; Rosen RC; Niederberger C; Nadel A; Sand M;
Institution
Pyrah Department of Urology, St. James University Hospital, Leeds, UK. ian.eardley@btinternet.com
Journal
Int J Clin Pract. 2007 Sep;61(9):1446-53. Epub 2007 Jul 26.
Abstract URL
Click here to view abstract

4. Erectile dysfunction in spinal cord-injured men: different treatment options.

Author
Moemen MN; Fahmy I; AbdelAal M; Kamel I; Mansour M; Arafa MM;
Institution
Cairo University, Almanial, Cairo, Egypt.
Journal
Int J Impot Res. 2008 Mar-Apr;20(2):181-7. Epub 2007 Aug 2.
Abstract URL
Click here to view abstract

5. Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial.

Author
Stanislavov R; Nikolova V; Rohdewald P;
Institution
Department of Obstetrics and Gynecology, Medical University Sofia, Faculty of Medicine, Sofia, Bulgaria.
Journal
Int J Impot Res. 2008 Mar-Apr;20(2):173-80. Epub 2007 Aug 16.
Abstract URL
Click here to view abstract

6. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.

Author
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G;
Institution
Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. amelman@aecom.yu.edu
Journal
Isr Med Assoc J. 2007 Mar;9(3):143-6.
Abstract URL
Click here to view abstract

7. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.

Author
Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC;
Institution
Department of Urology, Seoul National University Hospital, Seoul, Korea. jspaick@snu.ac.kr
Journal
J Sex Med. 2008 Apr;5(4):946-53. Epub 2008 Jan 21.
Abstract URL
Click here to view abstract

8. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.

Author
Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG;
Institution
University of California, San Francisco, CA, USA. isharlip@aol.com
Journal
J Sex Med. 2008 Mar;5(3):716-25.
Abstract URL
Click here to view abstract

9. Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study.

Author
Conaglen HM; Conaglen JV;
Institution
University of Waikato-Psychology, Hamilton, New Zealand. helen@tpc.org.nz
Journal
J Sex Med. 2008 May;5(5):1198-207. Epub 2008 Feb 25.
Abstract URL
Click here to view abstract

10. Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose.

Author
McCullough AR; Steidle CP; Klee B; Tseng LJ;
Institution
New York University School of Medicine, New York, New York 10016, USA. andy.mccullough@nyumc.org
Journal
Urology. 2008 Apr;71(4):686-92.
Abstract URL
Click here to view abstract
Pages: 1 2 3